| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/23/2009 | EP2134678A2 N-(5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain |
| 12/23/2009 | EP2134349A1 Aminoalkyl glucosamine phosphate compounds for treating autoimmune diseases |
| 12/23/2009 | EP2134176A1 Compounds and methods for enhancing mhc class ii therapies |
| 12/23/2009 | EP1796657B1 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 12/23/2009 | EP1682550B1 Substituted naphthyridinone derivatives |
| 12/23/2009 | EP1608654B1 8-SUBSTITUTED-6, 7, 8,9-TETRAHY9DROPYRIMIDO (1,2- a) PYRIMIDIN-4-ONE DERIVATIVES |
| 12/23/2009 | EP1549651B1 Pyrimidopyrimidones as kinase inhibitors |
| 12/23/2009 | EP1539205B1 Phytoprogestogenic extracts from rhizoma ligusticum chuanxiong and uses thereof |
| 12/23/2009 | EP1421174B1 Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof |
| 12/23/2009 | EP1296972B1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 12/23/2009 | EP1164874B1 Use of negatively charged, non-digestible polysaccharide hydrolysates for reducing transport through tight junctions of the intestin |
| 12/23/2009 | CN101611054A Humani zed antibody against amyloid beta |
| 12/23/2009 | CN101611036A Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 12/23/2009 | CN101611034A New triazabenzo[a]naphtho[2,l,8-cde]azulene derivatives, method for preparing the same and pharmaceutical compositions containing the same |
| 12/23/2009 | CN101611029A Succinate salt of 2-((4-(1-methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl) phenoxy)methyl)quinoline |
| 12/23/2009 | CN101611028A Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 12/23/2009 | CN101611013A Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
| 12/23/2009 | CN101611005A Substituted acetophenones useful as PDE4 inhibitors |
| 12/23/2009 | CN101610783A Therapeutic agent for spinal cord injury |
| 12/23/2009 | CN101610779A 5ht4受体拮抗药 5ht4 receptor antagonist |
| 12/23/2009 | CN101610777A Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative |
| 12/23/2009 | CN101610775A Analgesic agent comprising cyclic phosphatidic acid derivative |
| 12/23/2009 | CN101610774A Method of treating demyelination diseases |
| 12/23/2009 | CN101610764A Benzamide derivatives as EP4 receptor agonists |
| 12/23/2009 | CN101610762A Composition for improving brain function |
| 12/23/2009 | CN101607961A Eszopiclone crystal and composition thereof |
| 12/23/2009 | CN101607959A Dihydro quinolinone derivative, preparation method thereof and medicine composition taking same as main active ingredient |
| 12/23/2009 | CN101607951A Method for preparing escitalopram |
| 12/23/2009 | CN101607079A Application of GLP-1 and analogue thereof in preparing medicine for treating Alzheimer's disease |
| 12/23/2009 | CN101607078A Traditional Chinese medicine five-feng amino acid nutritional plaster matrix and preparation of externally applied plaster of matrix |
| 12/23/2009 | CN101607072A Pills (capsules) for awakening brain and opening orifice |
| 12/23/2009 | CN101607050A Medicine for treating facioplegia |
| 12/23/2009 | CN101607047A Method for treating headache disease by soaking feet with traditional Chinese medicine |
| 12/23/2009 | CN101607044A Method for curing head-eye vertigo by taking foot bath in traditional Chinese medicine solution |
| 12/23/2009 | CN101607042A Method for treating headache due to yin deficiency by soaking feet in Chinese medicament solution |
| 12/23/2009 | CN101607041A Method for treating headache due to yin deficiency by soaking feet in Chinese medicament solution |
| 12/23/2009 | CN101607038A Application of Chinese medicinal composition in preparing medicament for treating insomnia |
| 12/23/2009 | CN101607037A Detecting method of lanzhi brain-tranquilizing capsule |
| 12/23/2009 | CN101607036A Application of Chinese medicinal composition on in preparing medicament for treating depression |
| 12/23/2009 | CN101607030A Method for curing insomnia caused by severe mental pressure by soaking feet with traditional Chinese medicines |
| 12/23/2009 | CN101607029A Method for treating insomnia by soaking feet into Chinese medicament |
| 12/23/2009 | CN101606973A Shizandra berry soft capsule for improving sleep and preparation method thereof |
| 12/23/2009 | CN101606943A Use of paederosidic acid methyl ester in preparation of analgesic medicaments and/or anti-inflammatory medicaments |
| 12/23/2009 | CN101606937A Solid medicinal composition of lomerizine and preparation method thereof |
| 12/23/2009 | CN101606924A Local application emplastrum containing heparin and diclofenac |
| 12/23/2009 | CN101606923A Stable controlled-release rasagiline transdermal patch and preparation method thereof |
| 12/23/2009 | CN101606917A Sustained-release tablet of salt of huperzine A with one-time administration for everyday |
| 12/23/2009 | CN101606916A Pharmaceutical formulations of modafinil |
| 12/23/2009 | CN101606915A Novel pharmaceutical formulations of modafinil |
| 12/23/2009 | CN101606911A Risperidone dripping pill and preparing method thereof |
| 12/23/2009 | CN101606698A Natural colour viscera-nourishing nutritional noodles and preparation method |
| 12/23/2009 | CN101606692A Natural colour viscera-nourishing nutritional porridge and preparation method |
| 12/23/2009 | CN100572392C 截短tau蛋白 Truncated tau protein |
| 12/23/2009 | CN100572377C Derivatives of indol-2-one for treating neurological disorders, gastrointestinal disorders and cardiovascular disorder |
| 12/23/2009 | CN100572365C 1,2,4-triazole [4,3-alpha] chinoline -1-one derivative as antiepileptics medicine and its pharmaceutical salts |
| 12/23/2009 | CN100571729C Preparation of Chinese medicament for treating hemicrania |
| 12/23/2009 | CN100571726C Medicinal compositions |
| 12/23/2009 | CN100571725C Chinese-medicinal preparation for treating ischiodynia |
| 12/23/2009 | CN100571708C Medicinal composition having cooperative action |
| 12/23/2009 | CN100571701C Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 12/23/2009 | CN100571689C Transdermal therapeutic system provided with improved long-term attachment comfort |
| 12/23/2009 | CN100571687C Double sodium valproate orally disintegrating tablets and preparation method thereof |
| 12/23/2009 | CN100571679C Lidocaine hydrochloride partial film forming gel composition and uses thereof |
| 12/23/2009 | CA2765866A1 Pharmaceutical formulation |
| 12/23/2009 | CA2728675A1 Dibenzothiazepine derivatives and use thereof |
| 12/23/2009 | CA2728454A1 Thiazolyl- and oxazolyl-isoquinolinones and methods for using them |
| 12/23/2009 | CA2728376A1 6-1h-imidazo-quinazoline and quinolines derivatives/mao inhibitors for treating depression |
| 12/23/2009 | CA2728373A1 Aryl ketone as mri |
| 12/23/2009 | CA2728335A1 Novel phenylimidazole derivatives as pde10a enzyme inhibitors |
| 12/23/2009 | CA2728234A1 Use of isoindoles for the treatment of neurobehavioral disorders |
| 12/23/2009 | CA2728054A1 Pyrrolidine derivatives as nk2 receptor antagonists |
| 12/23/2009 | CA2728046A1 S1p1 receptor agonists and use thereof |
| 12/23/2009 | CA2727987A1 Renin inhibitors and method of use thereof |
| 12/23/2009 | CA2727979A1 Crystalline of eszopiclone, its composition, preparation and uses thereof |
| 12/23/2009 | CA2727914A1 Spirodiamine-diaryl ketoxime derivative technical field |
| 12/23/2009 | CA2727909A1 Anti-prion protein antibody fragment |
| 12/23/2009 | CA2727064A1 Combination of pilocarpin and methimazol for treating charcot-marietooth disease and related disorders |
| 12/23/2009 | CA2727036A1 Triazolopyridine jak inhibitor compounds and methods |
| 12/23/2009 | CA2726844A1 Triazolopyridine jak inhibitor compounds and methods |
| 12/23/2009 | CA2726164A1 Wnt protein signalling inhibitors |
| 12/23/2009 | CA2726161A1 A peptide derivative and a composition for promoting lacrimal secretion comprising the same |
| 12/23/2009 | CA2725940A1 Novel substituted azabenzoxazoles |
| 12/23/2009 | CA2725934A1 Novel substituted indoles |
| 12/23/2009 | CA2725657A1 Novel heteroaryl carboxamide derivatives |
| 12/23/2009 | CA2724449A1 5-ht3 receptor modulators, methods of making, and use thereof |
| 12/22/2009 | US7635775 Analgesics; central nervous system disorders ; antiarthritic agents; inflammatory bowel disorders; 2-[2-(S or R)-1-(4-chloro-2,5-dimethylbenzenesulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl]-N-[1-(R)-(pyrrolidin-N-ylcarbonyl-4-guanidino-but-1-yl]acetamide |
| 12/22/2009 | US7635774 Benzimidazole derivatives |
| 12/22/2009 | US7635751 For development of pharmaceutical preparations such as neutral nerve function regulator, circulatory function regulator, a cardiac function regulator, an immune function regulator, a digestive organ function regulator, metabolic function regulator |
| 12/22/2009 | US7635713 Preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, eclampsia, or eosinophil disorder; use in combination with a phosphodiesterase inhibitor; e.g. (5Z)-7-{1-[3-hydroxy-4-(3-methylphenyl)butyl]-3-oxopyrrolidin-2-yl}hept-5-enoic acid |
| 12/22/2009 | US7635703 as tyrosine, serine/threonine, cyclin-dependent kinases, HER protein; 5-{2-[3-[4-trifluoromethyl-1-(2-trimethylsilanyl-ethoxymethyl)-1H-imidazol-2-yl]-1-(2-trimethylsilanyl-ethoxymethyl)-1H-pyrazol-4-yl]-vinyl}-pyridine-3-carbaldehyde; antiproliferative, antiinflammatory agent, neurodegenerative diseases |
| 12/22/2009 | US7635681 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 12/22/2009 | US7635677 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 12/22/2009 | US7635556 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 12/22/2009 | US7635467 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 12/22/2009 | US7635464 Selective targeting of apoptotic cells |
| 12/22/2009 | CA2486859C Combination immediate release controlled release levodopa/carbidopa dosage forms |
| 12/22/2009 | CA2461248C Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists |
| 12/22/2009 | CA2447166C Delivery of erectile dysfunction drugs through an inhalation route |
| 12/22/2009 | CA2446990C Delivery of sedative-hypnotics through an inhalation route |
| 12/22/2009 | CA2446917C Delivery of antipsychotics through an inhalation route |